Natixis’s Biostar Pharmaceuticals BSPM Stock Holding History
Bought
Maintained
Sold
Other funds holding BSPM
AL
Natixis's BSPM Position: Q2 2014 in Review
Natixis sold out of Biostar Pharmaceuticals (BSPM) in Q2 2014, closing a stake of 3,829 shares — an estimated $54K sold.
Natixis first reported a position in BSPM in Q4 2013 and held it in 2 quarters. The position peaked at $54K in Q1 2014. 13 funds tracked by Wall St. Rank hold BSPM as of Q2 2014.
- Natixis reported no remaining Biostar Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
- Natixis sold 3,829 Biostar Pharmaceuticals shares in Q2 2014, an estimated $54K.
- Natixis first reported a position in Biostar Pharmaceuticals in Q4 2013 and held it in 2 quarters.
- Natixis's Biostar Pharmaceuticals position peaked at $54K in Q1 2014.
- 13 funds tracked by Wall St. Rank held Biostar Pharmaceuticals as of Q2 2014.
Based on Natixis's 13F filing for Q2 2014, filed 14 Aug 2014.